


See product citations (1)
QUICK LINKS
Cdk2 Inhibitor IV, NU6140 is a highly cell-permeable purine compound that displays anticancer properties and acts as a selective and ATP-competitive inhibitor of Cdks (IC50 = 6.6 µM, 0.41 µM, 5.5 µM, 15 µM and 3.9 µM for Cdk1/cyclin B, Cdk2/cyclin A, Cdk4/cyclin D, Cdk5/p25 and Cdk7/cyclin H, respectively). Cdk2 Inhibitor IV, NU6140 has been shown to cause cell cycle arrest at the G2/M phase and induce apoptosis by activating caspases and down-regulation survivin. Cdk2 Inhibitor IV, NU6140 has also been shown to synergistically potentiate paclitaxel cytotoxicity and apoptotic response in HeLa and OAW42 cells.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
NU 6140, 5 mg | sc-202531 | 5 mg | $147.00 |